Medication Adherence and Its Determinants among Women of Cardiovascular Disease of Tertiary Care Hospital, HyderabadFunding Students Prajwalika Scholarship program 2019, Women in Cardiology and related sciences association.
Background and Aim Adherence to long-term therapy for chronic illnesses in developed countries averages to 50%. In developing countries, the rates are even lower. Poor adherence to long-term therapies severely compromises the effectiveness of treatment making this a critical issue in population health both from the perspective of quality of life and of health economics. Cardiovascular diseases (CVDs) are the most common disorders affecting most of the productive age group. Therefore, an attempt has been made to determine medication adherence using the Morisky medication adherence scale-4 (MMAS-4) and its determinants in women patients with CVD.
Material and Methods A Hospital based cross-sectional study was conducted at outpatient block of General Medicine and Cardiology departments which included 175 women patients who were already diagnosed with CVD (with at least 3 months of medication) and those who were willing to give informed consent for participation. Semi structured questionnaire was used which consisted of sociodemographic variables, MMAS-4 to measure the level of adherence and various determinants such as socioeconomic, patient related, condition related, therapy related, and health system related.
Results Prevalence of medication adherence among women of CVDs using MMAS-4 was high, medium, and low among 39, 51, and 10%, respectively. Significant determinants found were socioeconomic, patient related, health system, and therapy related.
Conclusion Low-to-medium medication adherence was found to be high which needs to be addressed to reduce the morbidity and mortality associated with CVDs.
31 December 2020 (online)
© 2020. Women in Cardiology and Related Sciences. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol 1993; 72 (10) 68D-74D
- 2 Sabate E. World Health Organization. Adherence to Long Term Therapies. Evidence for Action. Geneva, Switzerland: World Health Organization 2003
- 3 Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353 (05) 487-497
- 4 World Health Organization. Cardiovascular diseases (CVDs). Fact sheets. Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) Accessed October 4, 2019
- 5 Xavier D, Pais P, Devereaux PJ. et al. CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 2008; 371 (9622) 1435-1442
- 6 Smith SC Jr, Allen J, Blair SN. et al. AHA; ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol 2006; 47 (10) 2130-2139
- 7 Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med 2012; 125 (09) 882-7.e1
- 8 Akeroyd JM, Chan WJ, Kamal AK, Palaniappan L, Virani SS. Adherence to cardiovascular medications in the South Asian population: a systematic review of current evidence and future directions. World J Cardiol 2015; 7 (12) 938-947
- 9 Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24 (01) 67-74
- 10 Thakur JS, Vijayvergiya R, Jaswal N, Ginsburg A. Assessment and barriers to medication adherence for secondary prevention of cardiovascular disease among patients with coronary artery disease in Chandigarh, India. Int J Non-Commun Dis 2016; 1: 37-41
- 11 Rao CR, Kamath VG, Shetty A, Kamath A. Treatment compliance among patients with hypertension and type 2 diabetes mellitus in a coastal population of southern India. Int J Prev Med 2014; 5 (08) 992-998
- 12 Venkatachalam J, Abrahm SB, Singh Z, Stalin P, Sathya GR. Determinants of patient’s adherence to hypertension medications in a rural population of Kancheepuram district in Tamil Nadu, South India. Indian J Community Med 2015; 40 (01) 33-37
- 13 Pandey VK, Aggarwal P, Kakkar R. Modified BG Prasad’s Socio-economic Classification-2018: The need of an update in the present scenario. Indian J Comm Health 2018; 30 (01) 82-84
- 14 Shankar SP, Suman Babu ISS, Ramya N. A study on usefulness of modified medication adherence scale in assessing adherence among hypertensive patients. Perspect Clin Res 2019; 10 (04) 163-167
- 15 Ramli A, Ahmad NS, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Prefer Adherence 2012; 6: 613-622
- 16 Awad A, Osman N, Altayib S. Medication adherence among cardiac patients in Khartoum State, Sudan: a cross-sectional study. Cardiovasc J Afr 2017; 28 (06) 350-355
- 17 van der Laan DM, Elders PJM, Boons CCLM, Nijpels G, Hugtenburg JG. Factors associated with nonadherence to cardiovascular medications: a cross-sectional study. J Cardiovasc Nurs 2019; 34 (04) 344-352
- 18 Gupta MC, Bhattacharjee A, Singh H. Evaluation of medication adherence patterns amongst anti-hypertensive drug users in a tertiary care hospital in north India. Int J Basic Clin Pharmacol 2016; 5: 2261-2266